Changes in Electrocardiographic (ECG) Ventricular Repolarization and Transthoracic Impedance Cardiography (ICG) Parameters in Patients with COVID-19 and After the Disease: Persistence and Prognostic Significance of These Changes
Launched by LITHUANIAN UNIVERSITY OF HEALTH SCIENCES · Nov 3, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how COVID-19 affects heart health, specifically focusing on changes in heart activity measured through electrocardiograms (ECG) and impedance cardiography (ICG). Researchers want to understand if these changes can lead to heart rhythm issues or other heart problems in people who have recovered from COVID-19, even two years after their illness. The goal is to find ways to predict and prevent long-term heart complications for these patients.
To participate in this study, you need to have been hospitalized for COVID-19 at least two years ago, and your COVID-19 diagnosis must have been confirmed with a specific test. The study is open to all genders, but some individuals may not qualify, such as those with certain heart devices like pacemakers, or those who cannot provide informed consent. If you join the study, you can expect to undergo some heart tests, and your participation could help improve understanding of heart health after COVID-19 for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient was hospitalized and treated in LUHS Kaunas Hospital for acute COVID-19 2 years ago (starting from 2022 January 1st).
- • During hospitalization COVID-19 was verified with PCR test from nasopharyngeal swab.
- Exclusion Criteria:
- • COVID-19 was not verified with PCR test from nasopharyngeal swab.
- • Patients who are unable to give informed consent for participation in study; vulnerable individuals: students if their participation is related to their studies, employees of healthcare institutions subordinate to the researcher, residents of social care institutions, and soldiers during their active military service.
- • Patients with an implanted pacemaker or cardioverter-defibrillator.
- • Patients whose permanent residence is not in Lithuania and who are not Lithuanian citizens.
- • Patients for whom it is not possible to perform ECG and ICG tests due to various circumstances.
- • Pregnant individuals (including individuals who were pregnant during the disease).
About Lithuanian University Of Health Sciences
The Lithuanian University of Health Sciences (LSMU) is a leading academic institution dedicated to advancing health sciences through innovative research and education. With a strong emphasis on interdisciplinary collaboration, LSMU conducts clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university's commitment to rigorous scientific inquiry is complemented by its state-of-the-art facilities and a network of experienced professionals, making it a pivotal player in the field of medical research in Lithuania and beyond. Through its clinical trials, LSMU strives to contribute valuable insights to the global medical community while fostering the next generation of healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported